Circadian rhythms play a crucial role in maintaining overall health and well-being. Disrupted circadian rhythms have been linked to various health issues, including higher levels of amyloid-beta, which is associated with Alzheimer’s disease. Recent research has shed light on the relationship between disrupted circadian rhythms and subsequent amyloid-beta levels in cognitively normal adults. The Study
Health
The recent announcement by the FDA expanding the indication of efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) to include treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP) marks a significant advancement in the field of neuromuscular disorder treatment. The approval of this new treatment option is set to revolutionize the way CIDP is managed and
Fenofibrate, a cholesterol drug, has shown promising results in reducing the progression of early eye disease among diabetes patients, according to the LENS trial. The trial revealed that fenofibrate decreased the advancement of early diabetic retinopathy or maculopathy by 27% over a span of 4 years compared to a placebo. This reduction was significant, with
The drug sample I received contained a shocking array of different substances, including nitazenes, fentanyl analogues, xylazine, diphenhydramine, caffeine, and medetomidine. The last substance, medetomidine, particularly caught my attention due to its unusual effects on patients experiencing overdoses. Unlike traditional opioids, medetomidine has a different mechanism of action and has been causing mass overdoses across
In the recent American Society of Clinical Oncology (ASCO) meeting, Dr. Roy Herbst from Yale Cancer Center discussed the exciting new data surrounding osimertinib (Tagrisso) in patients with EGFR-mutated non-small cell lung cancer (NSCLC) from both the LAURA and ADAURA trials. The data revealed improvements in progression-free survival (PFS) in stage III patients and the
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs in the body, including the kidneys. Recent analysis of medical records has indicated that individuals with SLE who are taking metformin may have lower rates of lupus nephritis, chronic kidney disease (CKD), and other complications. This finding suggests that metformin, commonly
Rheumatoid arthritis (RA) is a chronic autoimmune disease that not only affects the joints but also increases the risk of cardiovascular events and mortality in patients. Recent research conducted by Katherine P. Liao, MD, MPH, and her colleagues at Brigham and Women’s Hospital in Boston suggests that regular high-sensitivity cardiac troponin T (hs-cTnT) testing may
The recent study sheds light on the missed chances to provide proper treatment to drug overdose survivors covered by the Medicare program. This study highlights the challenges in managing chronic pain and the lack of access to essential medications and support for overdose survivors, leading to alarming statistics that indicate a higher likelihood of receiving
Recently, the FDA has approved two new immunotherapy-chemotherapy options for patients with primary advanced or recurrent endometrial cancer. This announcement marks a significant advancement in the treatment options available for patients with this type of cancer. The approval of these treatments comes as a result of successful phase III trials that demonstrated improved progression-free survival
Dr. Dean Ornish, from the University of California San Francisco, claims that an intensive lifestyle intervention can slow the progression of early Alzheimer’s disease. He boldly states, “The only side effects are good ones.” This statement suggests that the intervention not only helps with Alzheimer’s disease but also brings positive effects to other aspects of